InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 184884

Thursday, 07/31/2014 7:41:57 PM

Thursday, July 31, 2014 7:41:57 PM

Post# of 345745
thanks for the post! Some very interesting info that sounds very similar to AF's coverage of Peregrine Pharmaceuticals. I didn't know that AF was under investigation already when he was writing articles about Peregrine.

I like page 9... where they say "With your investigatory tools, you can better determine if collusion to manipulate the market price..." and I know you mentioned that the SEC did have some new analysis tools and I wonder if they are being put to good use. Many small biotechs may be in safer hands due to the work that "CREW" has initiated here, especially if the SEC acts accordingly.


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News